At a cost 95 percent less than Medicare’s prices, nonprofit generic drug company Civica premiered its first drug Aug. 3 with a treatment used for prostate cancer that has spread.
Read the full post on Becker's Hospital Review - Healthcare News
Civica launches 1st drug
